Background: Postpartum cerebral angiopathy is associated with the use of ergot alkaloids. The exact mechanism is unclear but may be related to their sympathomimetic properties, as evidenced in patients already on other ergot derivatives who deteriorated only after taking additional sympathomimetic drugs. We postulate that sympathomimetic agents, independent of ergot alkaloids, may produce the same complication.
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Henry G. Raroque, Jr, MD; Ganana Tesfa, MD; Phillip Purdy, MD Background: Postpartum cerebral angiopathy is associated with the use of ergot alkaloids. The exact mechanism is unclear but may be related to their sympathomimetic properties, as evidenced in patients already on other ergot derivatives who deteriorated only after taking additional sympathomimetic drugs. We postulate that sympathomimetic agents, independent of ergot alkaloids, may produce the same complication.
Case Description: A postpartum patient, initially presenting with headaches, subsequently manifested rapid neurological deterioration after ingesting isometheptene, a sympathomimetic drug. She was not on any ergot derivative but presented similar clinical and radiological manifestations. She experienced increased headache severity, visual disturbance, and seizures associated with multiple segmental cerebral vasoconstriction on angiography and increased T2-weighted signal in the occipital areas on magnetic resonance imaging.
Conclusions: This case is additional evidence that sympathomimetic actions of some drugs, such as ergot derivatives and isometheptene, may lead to postpartum cerebral angiopathy. Documentation of medication used by postpartum women suffering similar complications is needed to verify these findings. (Stroke. Case Report A 32-year-old woman, gravida 3, para 3, was admitted to the hospital after complaining of increasingly severe headaches 5 days after an uncomplicated pregnancy and delivery. She had a 4-year history of poorly defined headaches characterized as diffuse and throbbing, without aura, and occasionally associated with nausea. The headaches had occurred approximately every 3 months, were of variable duration, and were relieved by acetaminophen or aspirin. Aside from the persistence and increasing severity, her present headaches exhibited the same characteristics as those occurring during the previous 4-year period.
On initial presentation, her blood pressure, physical and neurological examinations, and routine laboratory tests, including urinalysis, were normal. Contrast computed tomography scan and cerebrospinal fluid analysis also were normal. She was treated with chlorpromazine 50 mg IV, and the headaches subsided. She was discharged and instructed to take a commercial preparation containing isometheptene mucate 65 mg per tablet, dichloralphenazone 100 mg per tablet, and acetaminophen 325 mg per tablet (Midrin, Carnrick Laboratories, Inc, Cedar Knolls, NJ). She was advised to take this medication as needed for headaches but not to exceed ingesting six tablets in 24 hours and 10 tablets in 1 week. She was also prescribed amitriptyline 25 mg every night, but she denied taking them.
After discharge, she experienced the headaches again, for which she took eight tablets of isometheptene within 24 hours. Subsequently, she complained of flashing lights and photophobia, followed immediately by generalized tonic-clonic seizures. She was readmitted. Her physical examination, including blood pressure, was (Figure, right panel) . After being treated with phenytoin, her seizures did not recur. In addition, her headache subsided with acetaminophen. A repeat cerebral angiography was not performed, but a repeat TCD was performed 6 days after the first study. The TCD showed persistent global elevation in velocity but normalization of the ratio of ACA to MCA velocity as well as near disappearance of the focal velocity elevation previously seen in the basilar artery. A repeat MRI 10 days later was normal.
Discussion
Our patient had a presentation similar to that of patients with toxemia and postpartum cerebral angiopathy. However, she did not have hypertension, proteinuria, or edema to satisfy the minimal clinical and laboratory criteria for toxemia5,6 and more likely had postpartum cerebral angiopathy. Her rapid deterioration occurred after the ingestion of more than the recommended amount of medication. The medication may have been excessive for anyone. Alternatively, the medication may have been contributory to a predisposed state or a progressing pathological process peculiar to the postpartum period.
Isometheptene, the major component of Midrin, is a sympathomimetic agent with direct vasoconstrictive activity on cranial and cerebral arterioles and is widely used in the treatment of migraine and other vascular headaches.3'7 To our knowledge, the syndrome pre-Stroke Vol 24, No 12 December 1993 sented by our patient has not been reported as a specific side effect of this drug. The only other documented case involving isometheptene was with a postpartum patient who was also on bromocriptine for lactation suppression.4 The patient experienced progressively severe headache and cardiovascular distress 6 days postpartum after ingesting three tablets of a commercial preparation containing isometheptene. Unfortunately, no angiographic studies were performed. The authors used the case to suggest a sympathomimetic interaction with bromocriptine as the mechanism for the complication, especially since the patient also had been on bromocriptine in a previous pregnancy but did not experience any complications. They supported this hypothesis by reporting another postpartum patient who was also on bromocriptine and who deteriorated only with the ingestion of another sympathomimetic drug, phenylpropanolamine. In this case, the patient showed a presentation similar to that of our patient, experiencing headache, blindness, and two generalized tonic-clonic seizures associated with cerebral vasoconstriction on angiography.
No specific mechanism has yet been proven for postpartum cerebral angiopathy, but mechanisms relat- vasoconstriction in certain vascular beds before any effects on blood pressure can be seen.10 Phenylpropanolamine, a commonly used nasal decongestant, acts through local vasoconstriction in the nasal mucosa. However, it also has pressor effects secondary to both vasoconstriction and increased cardiac output."
Overall, our case lends support to the hypothesis that postpartum cerebral angiopathy may arise from drugs with sympathomimetic properties. It also raises the question of whether postpartum patients are truly more vulnerable to the less potent sympathomimetic drugs. Documentation of medications, particularly those with sympathomimetic properties, in women suffering similar clinical and radiological manifestations during pregnancy and immediately after delivery is needed to verify these findings.
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